Pfizer (BUE:PFE) EV-to-Revenue

: 10.99 (As of Today)

View and export this data going back to . Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Pfizer's enterprise value is ARS180,724,186 Mil. Pfizer's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ARS16,442,197 Mil. Therefore, Pfizer's EV-to-Revenue for today is 10.99.

The historical rank and industry rank for Pfizer's EV-to-Revenue or its related term are showing as below:

BUE:PFE' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.38 Med: 4.23 Max: 8.82
Current: 3.56

During the past 13 years, the highest EV-to-Revenue of Pfizer was 8.82. The lowest was 2.38. And the median was 4.23.

BUE:PFE's EV-to-Revenue is ranked worse than
67.74% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.28 vs BUE:PFE: 3.56

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-23), Pfizer's stock price is ARS6933.50. Pfizer's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ARS5,793.58. Therefore, Pfizer's PS Ratio for today is 1.20.

Pfizer EV-to-Revenue Historical Data

The historical data trend for Pfizer's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

6.04

5.55

4.16

2.99

3.78

Pfizer Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															2.99	2.64	2.92	3.02	3.78

Competitive Comparison

For the Drug Manufacturers - General subindustry, Pfizer's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pfizer EV-to-Revenue Distribution

For the Drug Manufacturers industry and Healthcare sector, Pfizer's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Pfizer's EV-to-Revenue falls into.

Pfizer EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Pfizer's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	180724186.311	/	16442196.693
	=	10.99

Pfizer's current Enterprise Value is ARS180,724,186 Mil.
Pfizer's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS16,442,197 Mil.

Pfizer (BUE:PFE) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Pfizer's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	6933.50	/	5793.58
	=	1.20

Pfizer's share price for today is ARS6933.50.
Pfizer's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS5,793.58.

Pfizer EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pfizer's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Pfizer (BUE:PFE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (BUE:PFE) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

PFE:USA PFE:Peru PFE:Mexico PFE_KZ:Kazakhstan 1PFE:Italy PFEd:UK 0Q1N:UK PFE:Germany PFE:Chile PFE:Canada PFIZ34:Brazil PFE:Austria

Address

66 Hudson Boulevard East, New York, NY, USA, 10001-2192

Website

https://www.pfizer.com

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.